Thermo Fisher Scientific, Inc.
TMOThermo Fisher Scientific, Inc. is a global leader in scientific research and laboratory equipment, providing innovative products and services for life sciences, healthcare, and applied markets. Founded in 2006 through the merger of Thermo Electron and Fisher Scientific, the company specializes in laboratory instrumentation, analytical instruments, reagents, and consumables used in various science and clinical applications. It supports research institutions, pharmaceutical companies, and government agencies with solutions that advance scientific discovery and improve health.
Dividend History
Investors can expect a dividend payout of $0.43 per share, scheduled to be distributed in 55 days on January 15, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 15, 2026 | $0.43 | 2025-12-15 | 2025-12-15 |
| October 15, 2025 | $0.43 | 2025-09-15 | 2025-09-15 |
| July 15, 2025 | $0.43 | 2025-06-13 | 2025-06-13 |
| April 15, 2025 | $0.43 | 2025-03-14 | 2025-03-14 |
| January 15, 2025 | $0.39 | 2024-12-13 | 2024-12-13 |
Dividends Summary
- Thermo Fisher Scientific, Inc. has issued 56 dividend payments over the past 14 years
- The most recent dividend was paid 37 days ago, on October 15, 2025
- The highest dividend payed out to investors during this period was $0.43 per share
- The average dividend paid during this period was $0.23 per share.
Company News
Three companies - Trade Desk, Thermo Fisher, and Tapestry - are using stock buyback strategies to demonstrate market confidence, with varying approaches and commitment levels to shareholder returns.
The global cell harvesting market is projected to grow from $5.94 billion in 2024 to $20.08 billion by 2034, with a 12.95% CAGR, driven by increasing demand for regenerative medicine, cell-based therapies, and technological advancements in cell research.
Financial experts discussed stock picks on CNBC's 'Halftime Report Final Trades', highlighting Kimberly-Clark, Thermo Fisher Scientific, Westinghouse Air Brake Technologies, and Berkshire Hathaway as potential investment opportunities.
William Blair analyst Matt Larew initiated coverage of Thermo Fisher Scientific with an outperform rating, highlighting the company's competitive advantages and potential for recovery in the biopharma segment despite current market softness.
The article discusses research reports on Thermo Fisher Scientific, Micron Technology, and KLA. Thermo Fisher is benefiting from new product launches and strong financial performance, while Micron is seeing improved market conditions and rising demand for memory and storage. KLA is performing well due to strong wafer inspection business and AI ad...
